Refine your search
155 trials found
All(155)
Recruiting(123)
Not yet recruiting(32)
Recruiting
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Hemophilia A, Hemophilia B
Males
18+ years
22study location(s)
Recruiting
NCT05742217
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
Relapse Multiple Myeloma, Refractory Multiple Myeloma
Male or Female
18+ years
1study location(s)
Recruiting
NCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
Migraine
Females
16 - 49 years
2study location(s)
Recruiting
NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Male or Female
6 - 17 years
178study location(s)
Recruiting
NCT05046613
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Migraine
Females
0+ years
2study location(s)
Recruiting
NCT06641466
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Females
18 - 45 years
24study location(s)
Recruiting
NCT06920498
A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.
Healthy Participants
Male or Female
18 - 60 years
1study location(s)
Recruiting
NCT06910839
Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity
Overweight, Obesity
Male or Female
18 - 65 years
2study location(s)
Recruiting
NCT03844464
Safety and Efficacy of Lorbrena
Non-small Cell Lung Cancer, Pediatric Oncology, Pediatric Lung cancer, Pediatric Lung Neoplasm, Pediatric Lung Carcinoma
Male or Female
0+ years
1study location(s)
Recruiting
NCT04173273
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Male or Female
18 - 80 years
54study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(155)
Recruiting(123)
Not yet recruiting(32)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.